A Novel Immune-Related Gene Prognostic Index (IRGPI) in Pancreatic Adenocarcinoma (PAAD) and Its Implications in the Tumor Microenvironment

SIMPLE SUMMARY: Pancreatic adenocarcinoma (PAAD) is one of the leading causes of cancer death across the world, with extremely poor clinical outcomes within 5 years. From that end, survival prediction for such patients is essential, while in-service biomarkers are in need to be improved. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shujing, Szöllősi, Attila Gábor, Huang, Xufeng, Chang-Chien, Yi-Che, Hajdu, András
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688924/
https://www.ncbi.nlm.nih.gov/pubmed/36428747
http://dx.doi.org/10.3390/cancers14225652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688924/
https://www.ncbi.nlm.nih.gov/pubmed/36428747
http://dx.doi.org/10.3390/cancers14225652

Ejemplares similares